BIIB - Latest News
Biogen Inc. (BIIB), operates in Healthcare / Drug Manufacturers - General, trades on NASDAQ.
Market capitalization stands near $33.82B. Trailing twelve-month P/E ratio is 40.48. Beta to the broader market is 0.17.
The article list below shows the most recent BIIB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BIIB Headlines
3 Big Names Enjoying Renewed Analyst Backing
schaeffersresearch.com - Oct 12, 2026
Salesforce (CRM), Biogen (BIIB), and First Solar (FSLR) are all enjoying gains after landing fresh bull notes
Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Biogen, First Solar, GoDaddy, Hubspot, Palantir Technologies, Robinhood Markets, Snowflake, TeraWulf, T-Mobile US and More
247wallst.com - Oct 12, 2026
Big banks kick off third-quarter earnings season tomorrow, and Wall Street analysts are already reshuffling their bets with a wave of surprise upgrade
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
fool.com - Oct 11, 2026
One offers broad diversification at 0. 08% cost, while the other targets concentrated biotech growth with higher volatility.
Stock Picks From Seeking Alpha's September 2026 New Analysts
seekingalpha.com - Oct 7, 2026
Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and investment strategies.
Biogen expected to slightly beat third-quarter earnings as lupus trial data loom, Jefferies says
proactiveinvestors.com - Oct 6, 2026
Biogen Inc (NASDAQ:BIIB, XETRA:IDP) is expected to report a slight third-quarter earnings per share beat at $2. 14, against a consensus of $2.
How News Affects BIIB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BIIB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BIIB news questions
- What is the latest BIIB news headline?
- The most recent BIIB headline (Oct 12, 2026) is "3 Big Names Enjoying Renewed Analyst Backing". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BIIB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BIIB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BIIB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.